缺氧环境中外泌体miR-20a-5p通过CCND1/Hexokinase-2保护急性肾损伤小管上皮细胞线粒体的机制研究
批准号:
82070709
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
汤颖
依托单位:
学科分类:
泌尿系统损伤与修复
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
汤颖
中文摘要
线粒体异常导致肾小管上皮细胞坏死脱落,是急性肾损伤的重要机制。我们前期发现:缺氧时,小管上皮细胞分泌富含miR-20a-5p的外泌体能较好保护线粒体,促进小管上皮细胞增殖,减轻肾损害;蛋白组学结果发现miR-20a-5p干预后,肾组织Hexokinase-2(己糖激酶-2,定位于线粒体外膜的糖酵解关键蛋白)表达显著升高。通过双荧光素酶报告试验,我们证实定位在线粒体外膜、抑制线粒体活性的CCND1是miR-20a-5p下游靶基因。近期有研究报道,CCND1可竞争Hexokinase-2的线粒体外膜结合位点,损害线粒体,抑制细胞增殖。由此我们提出科学假设:缺氧时,外泌体miR-20a-5p下调CCND1进而促进Hexokinase-2富集于小管上皮细胞线粒体外膜,保护线粒体、促进ATP产生,保护肾脏。我们拟采用CCND1基因敲入小鼠及细胞实验阐明缺氧时外泌体miR-20a-5p对肾保护机制。
英文摘要
Mitochondria abnormality leads to necrosis and shedding of renal tubular epithelial cells, which is an important pathogenesis for acute kidney injury. We previously found that exosomes rich in miR-20a-5p secreted by hypoxic tubular epithelial cells protected mitochondria and promoted the proliferation of tubular epithelial cells to reduce damage. Proteomics analysis showed that after the intervention of miR-20a-5p, the expression of renal tissue Hexokinase-2 was significantly increased ,which is a key protein located at the mitochondrial outer membrane and closely related to glycolysis. Through the dual-luciferase reporting assay, we found that CCND1, which located in the mitochondrial outer membrane and inhibits mitochondrial activity, is the downstream target gene of miR-20a-5p. Current reports showed that CCND1 and Hexokinase-2 compete for the mitochondrial outer membrane binding site, causing mitochondrial damage and inhibiting cell proliferation. Therefore, we proposed the scientific hypothesis that : during hypoxia, exosomal miR-20a-5p down-regulates CCND1 and promotes Hexokinase-2 enrichment in the outer mitochondrial membrane of tubule epithelial cells, protecting mitochondria, promoting ATP production, and protecting the kidneys. We intend to use CCND1 gene knock-in mice and cell experiments to elucidate the protective mechanism of exosomal miR-20a-5p on kidney during hypoxia.
急性肾损伤是(AKI)是临床常见的急危重症,有较高的发病率和病死率,及时干预治疗是促进AKI恢复并阻止其向慢性肾脏病(CKD)进展的关键。然而目前AKI仍缺乏有效的治疗药物,亟待深入研究相关机制并寻找治疗新靶标。本项目从体内实验入手,探讨了外泌体miR-20a-5p在AKI中的作用及机制。我们发现缺氧时小管上皮细胞分泌富含miR-20a-5p的外泌体可促进小管上皮细胞增殖;而抑制miR-20a-5p可加重小管上皮细胞损伤。此外,体内实验也证实过表达miR-20a-5p显著减轻了AKI小鼠肾脏损伤。同时,我们探究了miR-20a-5p靶基因CCND1在AKI中的作用,结果发现CCND1在AKI中表达显著降低,过表达CCND1显著增强了脂肪酸氧化和糖酵解,促进ATP生成,减轻了AKI肾小管损伤。体外实验结果进一步证实CCND1通过激活AMPK信号通路促进脂肪酸氧化,减轻肾小管上皮细胞损伤。我们的研究为进一步深入阐明AKI的发病机制,寻找AKI治疗新靶点奠定了理论基础。
Annexin A13调控PKA/PLIN5介导的脂滴-
线粒体偶联减轻急性肾损伤的机制研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:汤颖
-
依托单位:
国内基金
海外基金